Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Controlled Substances topic
No spam. Unsubscribe anytime.
House creates medical advisory committee to guide scheduling of controlled substances, HB38 passes
Summary
The House approved HB38 to create an advisory panel of doctors, pharmacists and drug experts to recommend evidence-based scheduling decisions for substances (Schedules I–V). The bill passed after brief debate, 67–3, and will go to the Senate.
The Utah House on the floor approved House Bill 38 on scheduling of controlled substances, establishing an expert advisory committee to evaluate drugs and recommend whether they should be placed on Schedules I through V.
Sponsor Paul Rea told colleagues the intent is to base scheduling decisions on ‘‘evidence-based science’’ rather than ad hoc judgment. "So what we're doing here is we're putting together an advisory committee that we can run these drugs through so that they can advise us based on what the drug does and where it should be scheduled, be it a Schedule I through a Schedule V," Rea said during his presentation.
Representative Vickers, speaking in support, said the screening process should prevent policy driven by isolated incidents and noted the effort aligns Utah’s practice with careful medical review. Vickers described the system as "a very positive thing" and said he expected it would be used sparingly.
With summation waived, the House opened and closed voting on HB38; the clerk announced the bill passed this body 67 yes, 3 nays. The bill will be transmitted to the Utah Senate for consideration.
Why it matters: Scheduling determines criminal penalties, research access and clinical oversight. The bill centralizes technical review with clinicians and pharmacists, aiming to make future schedule changes more consistent and informed by medical expertise.
What’s next: HB38 moves to the Senate for its consideration.
